Welcome to the Genome Stability Group pages

Our research focuses on understanding how cells maintain integrity of their genomes in the face of internal and external damage, originating e.g. during DNA replication or upon exposure to chemotherapeutic agents. We use both basic science and translational approaches, the latter concentrating on high-grade serous ovarian cancer patient samples. Our aim is to provide biological insights that will be useful in clinical decision-making, either immediately or in the longer term.
Read more
@LabKauppi

Congratulations to the Keeney (@Spo11Rulz) and Jasin labs on yet another insightful paper on pseudoautosomal region… twitter.com/i/web/status/1…

CHEMORESPONSE-hankkeessa luodaan malli, jonka avulla kullekin munasarjasyöpäpotilaalle voidaan suunnitella hänen sy… twitter.com/i/web/status/1…

This #WorldCancerDay we want to thank all cancer researchers and medical professionals. These are the people curin… twitter.com/i/web/status/1…

Congratulations to the poster winners 1. Erdogan Erkan @AnnaVaharautio lab, 2. @barunlz from @LabKauppi and 3. Osca… twitter.com/i/web/status/1…

@TERVA_OvCa

sciencedirect.com/science/articl… "At current drug pricing, there is no PFS improvement in a #biomarker negative cohort that… twitter.com/i/web/status/1…

Our new paper on Functional imaging in #OvarianCancer. EF5 tracer reveals hypoxic areas inside FDG-avid tumors.… twitter.com/i/web/status/1…

BRD9 säätelee homologiseen rekombinaatioon perustuvaa DNA-korjausta ja on potentiaalinen terapiakohde herkistämään… twitter.com/i/web/status/1…

#OvarianCancer is the fifth leading cause of cancer deaths among women partly due to its minimal symptoms. It often… twitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.